Collagen Binding Properties of the Membrane Type-1 Matrix Metalloproteinase (MT1-MMP) Hemopexin C Domain
Eric M. Tam,Yi I. Wu,Georgina S. Butler,M. Sharon Stack,Christopher M. Overall
DOI: https://doi.org/10.1074/jbc.m206874200
IF: 5.485
2002-01-01
Journal of Biological Chemistry
Abstract:Up-regulation of the collagenolytic membrane type-1 matrix metalloproteinase (MT1-MMP) leads to increased MMP2 (gelatinase A) activation and MT1-MMP autolysis. The autocatalytic degradation product is a cell surface 44-kDa fragment of MT1-MMP (Gly285–Val582) in which the ectodomain consists of only the linker, hemopexin C domain and the stalk segment found before the transmembrane sequence. In the collagenases, hemopexin C domain exosites bind native collagen, which is required for triple helicase activity during collagen cleavage. Here we investigated the collagen binding properties and the role of the hemopexin C domain of MT1-MMP and of the 44-kDa MT1-MMP ectodomain in collagenolysis. Recombinant proteins, MT1-LCD (Gly285–Cys508), consisting of the linker and the hemopexin C domain, and MT1-CD (Gly315–Cys508), which consists of the hemopexin C domain only, were found to bind native type I collagen but not gelatin. Functionally, MT1-LCD inhibited collagen-induced MMP2 activation in fibroblasts, suggesting that interactions between collagen and endogenous MT1-MMP directly stimulate the cellular activation of pro-MMP2. MT1-LCD, but not MT1-CD, also blocked the cleavage of native type I collagen by MT1-MMP in vitro, indicating an important role for the MT1-MMP linker region in triple helicase activity. Similarly, soluble MT1-LCD, but not MT1-CD or peptide analogs of the MT1-MMP linker, reduced the invasion of type I collagen matrices by MDA-MB-231 cells as did the expression of recombinant 44-kDa MT1-MMP on the cell surface. Together, these studies demonstrate that generation of the 44-kDa MT1-MMP autolysis product regulates collagenolytic activity and subsequent invasive potential, suggesting a novel feedback mechanism for the control of pericellular proteolysis. Up-regulation of the collagenolytic membrane type-1 matrix metalloproteinase (MT1-MMP) leads to increased MMP2 (gelatinase A) activation and MT1-MMP autolysis. The autocatalytic degradation product is a cell surface 44-kDa fragment of MT1-MMP (Gly285–Val582) in which the ectodomain consists of only the linker, hemopexin C domain and the stalk segment found before the transmembrane sequence. In the collagenases, hemopexin C domain exosites bind native collagen, which is required for triple helicase activity during collagen cleavage. Here we investigated the collagen binding properties and the role of the hemopexin C domain of MT1-MMP and of the 44-kDa MT1-MMP ectodomain in collagenolysis. Recombinant proteins, MT1-LCD (Gly285–Cys508), consisting of the linker and the hemopexin C domain, and MT1-CD (Gly315–Cys508), which consists of the hemopexin C domain only, were found to bind native type I collagen but not gelatin. Functionally, MT1-LCD inhibited collagen-induced MMP2 activation in fibroblasts, suggesting that interactions between collagen and endogenous MT1-MMP directly stimulate the cellular activation of pro-MMP2. MT1-LCD, but not MT1-CD, also blocked the cleavage of native type I collagen by MT1-MMP in vitro, indicating an important role for the MT1-MMP linker region in triple helicase activity. Similarly, soluble MT1-LCD, but not MT1-CD or peptide analogs of the MT1-MMP linker, reduced the invasion of type I collagen matrices by MDA-MB-231 cells as did the expression of recombinant 44-kDa MT1-MMP on the cell surface. Together, these studies demonstrate that generation of the 44-kDa MT1-MMP autolysis product regulates collagenolytic activity and subsequent invasive potential, suggesting a novel feedback mechanism for the control of pericellular proteolysis. matrix metalloproteinase membrane type C domain C domain with linker soluble MT1-MMP tissue inhibitor of metalloproteinases Dulbecco's modified Eagle's medium bovine serum albumin concanavalin A phosphate-buffered saline horseradish peroxidase 7-methoxycoumarin-4-yl)acetyl Type I collagen is the most abundant protein of the extracellular matrix and is an important structural component in blood vessels, skin, tendons, ligaments, and bone (1Vuorio E. de Crombrugghe B. Annu. Rev. Biochem. 1990; 59: 837-872Crossref PubMed Scopus (384) Google Scholar). Accordingly, the synthesis and degradation of type I collagen is tightly regulated. Disruptions in this homeostasis can lead to diseases such as pulmonary fibrosis, scleroderma, arthritis, and osteoporosis, which, if untreated, can result in loss of tissue function and integrity. In a number of cancer cells, the capacity to degrade type I collagen and invade through type I collagen matrices often correlates with metastatic potential (2Egeblad M. Werb Z. Nat. Rev. Cancer. 2002; 2: 161-174Crossref PubMed Scopus (5079) Google Scholar), a characteristic that is as important for the local dissemination of tumor cells as type IV collagen degradation and basement membrane penetration is for metastasis (3Stetler-Stevenson W.G. Yu A.E. Semin. Cancer Biol. 2001; 11: 143-152Crossref PubMed Scopus (358) Google Scholar). Despite the importance of maintaining correct collagen homeostasis in tissues, the proteases responsible for type I collagen degradation in vivo remain unclear. An intracellular pathway may play an important role in collagen degradation (4Overall C.M. Sodek J. Davidovitch Z. Biological Mechanisms of Tooth Eruption and Root Resorption. EBSCO Media, Birmingham, Alabama1988: 303-312Google Scholar) that, in bone, utilizes the cysteine protease cathepsin K at low pH (5Saftig P. Hunziker E. Wehmeyer O. Jones S. Boyde A. Rommerskirch W. Moritz J.D. Schu P. von Figura K. Proc. Natl. Acad. Sci. U. S. A. 1998; 95: 13453-13458Crossref PubMed Scopus (748) Google Scholar). Extracellularly, fibrillar type I collagen may be degraded at neutral pH by several matrix metalloproteinases (MMPs),1 a 24-member family of zinc-dependent endopeptidases in humans (2Egeblad M. Werb Z. Nat. Rev. Cancer. 2002; 2: 161-174Crossref PubMed Scopus (5079) Google Scholar). The major collagenolytic MMPs are the secreted collagenases, MMP1, MMP8, and MMP13 (6Nagase H. Woessner Jr., J.F. J. Biol. Chem. 1999; 274: 21491-21494Abstract Full Text Full Text PDF PubMed Scopus (3852) Google Scholar), and the cell surface membrane type 1 (MT1)-MMP (7Pei D. Weiss S.J. J. Biol. Chem. 1996; 271: 9135-9140Abstract Full Text Full Text PDF PubMed Scopus (364) Google Scholar, 8Ohuchi E. Imai K. Fujii Y. Sato H. Seiki M. Okada Y. J. Biol. Chem. 1997; 272: 2446-2451Abstract Full Text Full Text PDF PubMed Scopus (828) Google Scholar). MT1-MMP also activates collagenase-2 (MMP13) (9Cowell S. Knauper V. Stewart M.L. D'Ortho M.P. Stanton H. Hembry R.M. Lopez-Otin C. Reynolds J.J. Murphy G. Biochem. J. 1998; 331: 453-458Crossref PubMed Scopus (152) Google Scholar) and is the primary activator of MMP2 (10Sato H. Takino T. Okada Y. Cao J. Shinagawa A. Yamamoto E. Seiki M. Nature. 1994; 370: 61-65Crossref PubMed Scopus (2365) Google Scholar), a gelatinase that exhibits weak native type I collagenolytic activity (11Sodek J. Overall C.M. Matrix Suppl. 1992; 1: 352-362PubMed Google Scholar, 12Aimes R.T. Quigley J.P. J. Biol. Chem. 1995; 270: 5872-5876Abstract Full Text Full Text PDF PubMed Scopus (829) Google Scholar, 13Patterson M.L. Atkinson S.J. Knauper V. Murphy G. FEBS Lett. 2001; 503: 158-162Crossref PubMed Scopus (172) Google Scholar).MMPs share a common overall structure consisting of a propeptide, catalytic domain, linker (also called a hinge), and a hemopexin C domain (14Overall C.M. Methods Mol. Biol. 2001; 151: 79-120PubMed Google Scholar). Whereas the majority of MMPs are secreted as latent zymogens, MT-MMPs, the largest subgroup of MMPs, are membrane-anchored by the presence of a type I transmembrane sequence and cytoplasmic tail (MT1-, MT2-, MT3-, and MT5-MMP) or by glycosylphosphatidylinositol linkage (MT4- and MT6-MMP) (14Overall C.M. Methods Mol. Biol. 2001; 151: 79-120PubMed Google Scholar). MT1-MMP is activated intracellularly by proprotein convertase-dependent and -independent pathways (15Yana I. Weiss S.J. Mol. Biol. Cell. 2000; 11: 2387-2401Crossref PubMed Scopus (268) Google Scholar, 16Rozanov D.V. Deryugina E.I. Ratnikov B.I. Monosov E.Z. Marchenko G.N. Quigley J.P. Strongin A.Y. J. Biol. Chem. 2001; 276: 25705-25714Abstract Full Text Full Text PDF PubMed Scopus (145) Google Scholar) and is expressed as an active protease on the surface of many normal and pathological cell types (10Sato H. Takino T. Okada Y. Cao J. Shinagawa A. Yamamoto E. Seiki M. Nature. 1994; 370: 61-65Crossref PubMed Scopus (2365) Google Scholar, 17Takino T. Sato H. Yamamoto E. Seiki M. Gene (Amst.). 1995; 155: 293-298Crossref PubMed Scopus (93) Google Scholar). The importance of MT1-MMP is indicated by its requirement for the invasion of endothelial and cancer cells through type I collagen matrices (18Galvez B.G. Matias-Roman S. Albar J.P. Sanchez-Madrid F. Arroyo A.G. J. Biol. Chem. 2001; 276: 37491-37500Abstract Full Text Full Text PDF PubMed Scopus (202) Google Scholar, 19Belien A.T. Paganetti P.A. Schwab M.E. J. Cell Biol. 1999; 144: 373-384Crossref PubMed Scopus (202) Google Scholar, 20Aznavoorian S. Moore B.A. Alexander-Lister L.D. Hallit S.L. Windsor L.J. Engler J.A. Cancer Res. 2001; 61: 6264-6275PubMed Google Scholar). Moreover, mice deficient in MT1-MMP developed severe aberrations in type I collagen-abundant tissues, such as bone and skin, and the mice exhibited arthritis and scleroderma (21Holmbeck K. Bianco P. Caterina J. Yamada S. Kromer M. Kuznetsov S.A. Mankani M. Robey P.G. Poole A.R. Pidoux I. Ward J.M. Birkedal-Hansen H. Cell. 1999; 99: 81-92Abstract Full Text Full Text PDF PubMed Scopus (1098) Google Scholar, 22Zhou Z. Apte S.S. Soininen R. Cao R. Baaklini G.Y. Rauser R.W. Wang J. Cao Y. Tryggvason K. Proc. Natl. Acad. Sci. U. S. A. 2000; 97: 4052-4057Crossref PubMed Scopus (682) Google Scholar). In humans, homoallelic loss-of-function mutations in the MMP2 gene result in excessive bone resorption and arthritis (23Martignetti J.A. Aqeel A.A. Sewairi W.A. Boumah C.E. Kambouris M. Mayouf S.A. Sheth K.V. Eid W.A. Dowling O. Harris J. Glucksman M.J. Bahabri S. Meyer B.F. Desnick R.J. Nat. Genet. 2001; 28: 261-265Crossref PubMed Scopus (247) Google Scholar). This condition resembles the phenotype of the MT1-MMP knockout mouse, supporting the close functional connection of MMP2 and MT1-MMP in regulating pericellular collagen homeostasis in mice and humans.Native type I collagen consists of two α1(I) chains and one α2(I) chain interwound in a right-handed triple helix that is resistant to cleavage by most proteinases at neutral pH with the exception of the MMP collagenases (14Overall C.M. Methods Mol. Biol. 2001; 151: 79-120PubMed Google Scholar). Because the active site of collagenolytic MMPs can only accommodate a single α-chain, cleavage of the three α-chains occurs sequentially at the single collagenase-susceptible site, Gly775-Ile/Leu776, to generate ¾ and ¼ collagen fragments. To achieve this, the collagen helix must be initially unwound by a triple helicase mechanism in order to expose the scissile bonds. This critical step requires the presence of collagen-binding exosites (14Overall C.M. Methods Mol. Biol. 2001; 151: 79-120PubMed Google Scholar), in addition to elements within the active site (24Knauper V. Patterson M.L. Gomis-Ruth F.X. Smith B. Lyons A. Docherty A.J. Murphy G. Eur. J. Biochem. 2001; 268: 1888-1896Crossref PubMed Scopus (17) Google Scholar, 25Chung L. Shimokawa K. Dinakarpandian D. Grams F. Fields G.B. Nagase H. J. Biol. Chem. 2000; 275: 29610-29617Abstract Full Text Full Text PDF PubMed Scopus (118) Google Scholar, 26Brandstetter H. Grams F. Glitz D. Lang A. Huber R. Bode W. Krell H.W. Engh R.A. J. Biol. Chem. 2001; 276: 17405-17412Abstract Full Text Full Text PDF PubMed Scopus (128) Google Scholar). In MMP1, MMP8, and MMP13, the hemopexin C domain supports binding to collagen and is required for native collagen cleavage (27Allan J.A. Hembry R.M. Angal S. Reynolds J.J. Murphy G. J. Cell Sci. 1991; 99: 789-795Crossref PubMed Google Scholar, 28Clark I.M. Cawston T.E. Biochem. J. 1989; 263: 201-206Crossref PubMed Scopus (160) Google Scholar, 29Windsor L.J. Birkedal-Hansen H. Birkedal-Hansen B. Engler J.A. Biochemistry. 1991; 30: 641-647Crossref PubMed Scopus (72) Google Scholar, 30Murphy G. Allan J.A. Willenbrock F. Cockett M.I. O'Connell J.P. Docherty A.J. J. Biol. Chem. 1992; 267: 9612-9618Abstract Full Text PDF PubMed Google Scholar, 31Knauper V. Osthues A. DeClerck Y.A. Langley K.E. Blaser J. Tschesche H. Biochem. J. 1993; 291: 847-854Crossref PubMed Scopus (99) Google Scholar, 32Knauper V. Cowell S. Smith B. Lopez-Otin C. O'Shea M. Morris H. Zardi L. Murphy G. J. Biol. Chem. 1997; 272: 7608-7616Abstract Full Text Full Text PDF PubMed Scopus (294) Google Scholar). Deletion or mutation of the MMP8 linker also reduces collagenolysis (33Hirose T. Patterson C. Pourmotabbed T. Mainardi C.L. Hasty K.A. Proc. Natl. Acad. Sci. U. S. A. 1993; 90: 2569-2573Crossref PubMed Scopus (124) Google Scholar, 34Knauper V. Docherty A.J. Smith B. Tschesche H. Murphy G. FEBS Lett. 1997; 405: 60-64Crossref PubMed Scopus (46) Google Scholar). Furthermore, synthetic peptide analogs of the MMP1 linker bound collagen and inhibited collagen cleavage (35de Souza S.J. Brentani R. J. Biol. Chem. 1992; 267: 13763-13767Abstract Full Text PDF PubMed Google Scholar). Interestingly, the 35-amino acid residue linker of MT1-MMP is twice the length of other collagenase linkers (18 residues); however, the significance of this and its role in collagen cleavage have yet to be examined.The regulation of MT1-MMP activity, MMP2 activation and pericellular type I collagen levels is complex. In a variety of cells, stimulation by fibrillar type I collagen has been shown to increase the cell surface expression of MT1-MMP and induce the cellular activation of pro-MMP2 (36Azzam H.S. Thompson E.W. Cancer Res. 1992; 52: 4540-4544PubMed Google Scholar, 37Gilles C. Polette M. Seiki M. Birembaut P. Thompson E.W. Lab. Invest. 1997; 76: 651-660PubMed Google Scholar, 38Tomasek J.J. Halliday N.L. Updike D.L. Ahern-Moore J.S., Vu, T.K. Liu R.W. Howard E.W. J. Biol. Chem. 1997; 272: 7482-7487Abstract Full Text Full Text PDF PubMed Scopus (165) Google Scholar, 39Haas T.L. Davis S.J. Madri J.A. J. Biol. Chem. 1998; 273: 3604-3610Abstract Full Text Full Text PDF PubMed Scopus (323) Google Scholar, 40Ellerbroek S.M. Fishman D.A. Kearns A.S. Bafetti L.M. Stack M.S. Cancer Res. 1999; 59: 1635-1641PubMed Google Scholar, 41Ruangpanit N. Chan D. Holmbeck K. Birkedal-Hansen H. Polarek J. Yang C. Bateman J.F. Thompson E.W. Matrix Biol. 2001; 20: 193-203Crossref PubMed Scopus (59) Google Scholar, 42Ellerbroek S.M., Wu, Y.I. Overall C.M. Stack M.S. J. Biol. Chem. 2001; 276: 24833-24842Abstract Full Text Full Text PDF PubMed Scopus (146) Google Scholar). This response is in part dependent on β1 integrin clustering and signaling (40Ellerbroek S.M. Fishman D.A. Kearns A.S. Bafetti L.M. Stack M.S. Cancer Res. 1999; 59: 1635-1641PubMed Google Scholar, 42Ellerbroek S.M., Wu, Y.I. Overall C.M. Stack M.S. J. Biol. Chem. 2001; 276: 24833-24842Abstract Full Text Full Text PDF PubMed Scopus (146) Google Scholar, 43Seltzer J.L. Lee A.Y. Akers K.T. Sudbeck B. Southon E.A. Wayner E.A. Eisen A.Z. Exp. Cell Res. 1994; 213: 365-374Crossref PubMed Scopus (122) Google Scholar) and is potentially self-regulating, since type I collagen is susceptible to MT1-MMP and MMP2 proteolysis (14Overall C.M. Methods Mol. Biol. 2001; 151: 79-120PubMed Google Scholar, 44Ellerbroek S.M. Stack M.S. Bioessays. 1999; 21: 940-949Crossref PubMed Scopus (133) Google Scholar). Concentration of MT1-MMP by overexpression (45Butler G.S. Butler M.J. Atkinson S.J. Will H. Tamura T. van Westrum S.S. Crabbe T. Clements J. d'Ortho M.P. Murphy G. J. Biol. Chem. 1998; 273: 871-880Abstract Full Text Full Text PDF PubMed Scopus (538) Google Scholar, 46Hernandez-Barrantes S. Toth M. Bernardo M.M. Yurkova M. Gervasi D.C. Raz Y. Sang Q.A. Fridman R. J. Biol. Chem. 2000; 275: 12080-12089Abstract Full Text Full Text PDF PubMed Scopus (272) Google Scholar) or clustering interactions (47Overall C.M. Tam E. McQuibban G.A. Morrison C. Wallon U.M. Bigg H.F. King A.E. Roberts C.R. J. Biol. Chem. 2000; 275: 39497-39506Abstract Full Text Full Text PDF PubMed Scopus (85) Google Scholar, 48Itoh Y. Takamura A. Ito N. Maru Y. Sato H. Suenaga N. Aoki T. Seiki M. EMBO J. 2001; 20: 4782-4793Crossref PubMed Scopus (337) Google Scholar, 49Lehti K. Lohi J. Juntunen M.M. Pei D. Keski-Oja J. J. Biol. Chem. 2002; 277: 8440-8448Abstract Full Text Full Text PDF PubMed Scopus (115) Google Scholar, 50Overall C.M. Sodek J. J. Biol. Chem. 1990; 265: 21141-21151Abstract Full Text PDF PubMed Google Scholar) favors MMP2 activation and collagenolysis (50Overall C.M. Sodek J. J. Biol. Chem. 1990; 265: 21141-21151Abstract Full Text PDF PubMed Google Scholar). Concomitant with increased MT1-MMP expression and MMP2 activation is the autocatalytic processing of MT1-MMP at Gly284–Gly285 to shed the catalytic domain from the hemopexin C domain, which is retained on the cell membrane (40Ellerbroek S.M. Fishman D.A. Kearns A.S. Bafetti L.M. Stack M.S. Cancer Res. 1999; 59: 1635-1641PubMed Google Scholar, 46Hernandez-Barrantes S. Toth M. Bernardo M.M. Yurkova M. Gervasi D.C. Raz Y. Sang Q.A. Fridman R. J. Biol. Chem. 2000; 275: 12080-12089Abstract Full Text Full Text PDF PubMed Scopus (272) Google Scholar, 51Lehti K. Lohi J. Valtanen H. Keski-Oja J. Biochem. J. 1998; 334: 345-353Crossref PubMed Scopus (201) Google Scholar). Hence, the ectodomain of the residual 44-kDa MT1-MMP fragment (Gly285–Val582) on the cell surface consists of the linker, hemopexin C domain, and stalk segment only (see Fig. 1 A, ii) and thus is catalytically inactive. The significance of the 44-kDa MT1-MMP in vivo is not clear. In addition to being present following cell binding to type I collagen, the 44-kDa MT1-MMP has also been detected on the surface of tumor cells (40Ellerbroek S.M. Fishman D.A. Kearns A.S. Bafetti L.M. Stack M.S. Cancer Res. 1999; 59: 1635-1641PubMed Google Scholar, 51Lehti K. Lohi J. Valtanen H. Keski-Oja J. Biochem. J. 1998; 334: 345-353Crossref PubMed Scopus (201) Google Scholar). During MMP2 activation, TIMP-2-free MT1-MMP must be in close proximity to a trimeric complex of MT1-MMP·TIMP-2·pro-MMP2 in order to activate the bound pro-MMP2 (52Kinoshita T. Sato H. Okada A. Ohuchi E. Imai K. Okada Y. Seiki M. J. Biol. Chem. 1998; 273: 16098-16103Abstract Full Text Full Text PDF PubMed Scopus (258) Google Scholar). The mechanisms of MT1-MMP oligomerization are not clear. The recombinant hemopexin C domain of MT1-MMP did not form oligomers in solution or modulate MMP2 activation when added to cells (47Overall C.M. Tam E. McQuibban G.A. Morrison C. Wallon U.M. Bigg H.F. King A.E. Roberts C.R. J. Biol. Chem. 2000; 275: 39497-39506Abstract Full Text Full Text PDF PubMed Scopus (85) Google Scholar). Recent reports using transmembrane MT1-MMP chimera and deletion mutants have suggested that the hemopexin C domain can mediate homophilic complex formation of cellular MT1-MMP for efficient MMP2 activation (48Itoh Y. Takamura A. Ito N. Maru Y. Sato H. Suenaga N. Aoki T. Seiki M. EMBO J. 2001; 20: 4782-4793Crossref PubMed Scopus (337) Google Scholar, 49Lehti K. Lohi J. Juntunen M.M. Pei D. Keski-Oja J. J. Biol. Chem. 2002; 277: 8440-8448Abstract Full Text Full Text PDF PubMed Scopus (115) Google Scholar). Expression of a transmembrane-tethered MT1-MMP hemopexin C domain lacking the linker, termed PEX (Thr313–Val582), in HT1080 cells inhibited MT1-MMP oligomerization, the cellular activation of pro-MMP2, and Matrigel invasion (48Itoh Y. Takamura A. Ito N. Maru Y. Sato H. Suenaga N. Aoki T. Seiki M. EMBO J. 2001; 20: 4782-4793Crossref PubMed Scopus (337) Google Scholar), a function previously attributed to MMP2 proteolytic activity against type IV collagen (53Albini A. Melchiori A. Santi L. Liotta L.A. Brown P.D. Stetler-Stevenson W.G. J. Natl. Cancer Inst. 1991; 83: 775-779Crossref PubMed Scopus (311) Google Scholar).Considering that MT1-MMP is a collagenase, we hypothesized that exosites on the hemopexin C domain would bind to type I collagen and be essential for collagenolytic activity. Thus, the autolytically generated 44-kDa MT1-MMP ectodomain would be predicted to modulate pericellular collagenolysis on the membrane through dominant-negative interactions. Since native type I collagen stimulates MMP2 activation, we also hypothesized that collagen binding by the hemopexin C domain of MT1-MMP would modulate MMP2 activation with 44-kDa MT1-MMP opposing these effects in vivo. Experiments reported here demonstrate that collagen binding by the MT1-MMP hemopexin C domain is essential for collagenolytic activity and enhancement of MMP2 activation by MT1-MMP. Inhibition of this interaction either in vitro or on the cell surface inhibits collagen degradation. Together, these studies suggest a novel feedback mechanism through which generation of the 44-kDa MT1-MMP autolysis product regulates pericellular collagenolytic activity and subsequent invasive potential.DISCUSSIONAs an integral membrane protein, MT1-MMP appears suited for coordinating the homeostatic catabolism of pericellular type I collagen under the guide of the cell (62Nakahara H. Howard L. Thompson E.W. Sato H. Seiki M. Yeh Y. Chen W.T. Proc. Natl. Acad. Sci. U. S. A. 1997; 94: 7959-7964Crossref PubMed Scopus (360) Google Scholar, 63Nabeshima K. Inoue T. Shimao Y. Okada Y. Itoh Y. Seiki M. Koono M. Cancer Res. 2000; 60: 3364-3369PubMed Google Scholar, 64Lehti K. Valtanen H. Wickstrom S. Lohi J. Keski-Oja J. J. Biol. Chem. 2000; 275: 15006-15013Abstract Full Text Full Text PDF PubMed Scopus (144) Google Scholar, 65Hotary K. Allen E. Punturieri A. Yana I. Weiss S.J. J. Cell Biol. 2000; 149: 1309-1323Crossref PubMed Scopus (507) Google Scholar). MT1-MMP mediates collagen degradation directly by cleaving native collagen and, indirectly, by activating MMP13 (9Cowell S. Knauper V. Stewart M.L. D'Ortho M.P. Stanton H. Hembry R.M. Lopez-Otin C. Reynolds J.J. Murphy G. Biochem. J. 1998; 331: 453-458Crossref PubMed Scopus (152) Google Scholar) and the gelatinase and weak collagenase, MMP2 (11Sodek J. Overall C.M. Matrix Suppl. 1992; 1: 352-362PubMed Google Scholar, 12Aimes R.T. Quigley J.P. J. Biol. Chem. 1995; 270: 5872-5876Abstract Full Text Full Text PDF PubMed Scopus (829) Google Scholar, 13Patterson M.L. Atkinson S.J. Knauper V. Murphy G. FEBS Lett. 2001; 503: 158-162Crossref PubMed Scopus (172) Google Scholar). Spatially and temporally, these two distinct activities of MT1-MMP regulate collagenolytic and gelatinolytic activities on the cell surface. Since MT1-MMP is a critical initiator and effector in the pericellular collagenolytic cascade, the regulation of its biological activity is very important in physiological and pathological collagen remodeling. The studies reported here have revealed the importance of the MT1-MMP hemopexin C domain and linker in the mechanism of collagen cleavage and demonstrated the role of collagen binding to MT1-MMP in stimulating MMP2 activation by cells. Moreover, these actions may be modulated in a dominant negative manner by the 44-kDa remnant form of MT1-MMP on the cell surface, revealing a novel regulatory function in proteolysis for an autolytic fragment of a protease.The structure of collagen presents a challenge for proteolytic cleavage, as indicated by the lowk cat/K m values for collagenases (66Welgus H.G. Jeffrey J.J. Stricklin G.P. Roswit W.T. Eisen A.Z. J. Biol. Chem. 1980; 255: 6806-6813Abstract Full Text PDF PubMed Google Scholar). Despite several studies from a number of laboratories, the triple helicase mechanism remains enigmatic (14Overall C.M. Methods Mol. Biol. 2001; 151: 79-120PubMed Google Scholar). Our use of recombinant domains and polypeptides to probe the exosite requirements of MT1-MMP for collagenolysis revealed similar domain requirements for triple helicase activity as the secreted collagenases. The binding of the MT1-MMP hemopexin C domain, with or without the linker, to native collagen is consistent with previous reports for the collagenolytic MMPs (27Allan J.A. Hembry R.M. Angal S. Reynolds J.J. Murphy G. J. Cell Sci. 1991; 99: 789-795Crossref PubMed Google Scholar, 30Murphy G. Allan J.A. Willenbrock F. Cockett M.I. O'Connell J.P. Docherty A.J. J. Biol. Chem. 1992; 267: 9612-9618Abstract Full Text PDF PubMed Google Scholar, 31Knauper V. Osthues A. DeClerck Y.A. Langley K.E. Blaser J. Tschesche H. Biochem. J. 1993; 291: 847-854Crossref PubMed Scopus (99) Google Scholar, 32Knauper V. Cowell S. Smith B. Lopez-Otin C. O'Shea M. Morris H. Zardi L. Murphy G. J. Biol. Chem. 1997; 272: 7608-7616Abstract Full Text Full Text PDF PubMed Scopus (294) Google Scholar). The hemopexin C domain of MMP2, in contrast, does bind native collagen stably (57Wallon U.M. Overall C.M. J. Biol. Chem. 1997; 272: 7473-7481Abstract Full Text Full Text PDF PubMed Scopus (97) Google Scholar). Interestingly, the MT1-MMP hemopexin C domain does not bind denatured collagen. This suggests that, following cleavage, subsequent denaturation of the collagen would result in the release of MT1-MMP from the cleaved substrate facilitating turnover.Inhibition of sMT1-MMP collagen cleavage using MT1-MMP hemopexin C domain constructs required the presence of the linker, indicating that collagen binding, by the hemopexin C domain alone, is not sufficient to disrupt collagenolysis. This requirement was also observed in MMP2 collagenolysis, since MT1-LCD, but not MT1-CD, blocked MMP2 cleavage of native collagen. Protein engineering studies of MMP1 and MMP8 have previously shown a role for the linker in triple helicase activity (33Hirose T. Patterson C. Pourmotabbed T. Mainardi C.L. Hasty K.A. Proc. Natl. Acad. Sci. U. S. A. 1993; 90: 2569-2573Crossref PubMed Scopus (124) Google Scholar, 34Knauper V. Docherty A.J. Smith B. Tschesche H. Murphy G. FEBS Lett. 1997; 405: 60-64Crossref PubMed Scopus (46) Google Scholar, 35de Souza S.J. Brentani R. J. Biol. Chem. 1992; 267: 13763-13767Abstract Full Text PDF PubMed Google Scholar); however, our studies have revealed some unique features of the MT1-MMP linker. De Souza et al. (67De Souza S.J. Pereira H.M. Jacchieri S. Brentani R.R. FASEB J. 1996; 10: 927-930Crossref PubMed Scopus (48) Google Scholar) proposed that the MMP1 collagenase linker, due to its proline content, intercalates with the collagen triple helix, thereby displacing individual α-chains for cleavage. We found that MT1-MMP linker peptide analogs of either the full-length 35-amino acid residue linker or the 18-amino acid residue region, corresponding to that found in the secreted collagenases, did not bind native or denatured type I collagen. These results indicate that the MT1-MMP linker may not bind or intercalate with the collagen triple helix as proposed for the MMP1 linker. Indeed, the low glycine content renders triple helix formation by these linkers impossible. Potentially, the full collagen binding exosite of the MT1-MMP hemopexin C domain that recognizes the ¾-¼ collagen site may span the linker/hemopexin C domain junction, thereby accounting for the lack of collagen binding by the linker analogs alone and the ineffectiveness of MTI-CD in blocking collagenolysis. The MT1-MMP linker, when connected to the hemopexin C domain, may act as a specificity determinant directing binding of the protease to the ¾-¼ collagen cleavage site. Thus, competition from MT1-LCD, but not MT1-CD, may block MT1-MMP from binding collagen here and so inhibit cleavage. Topographically, the MT1-MMP, and other collagenase linkers, may also correctly configure the catalytic domain relative to the hemopexin C domain for collagenolytic competence. Indeed, the MT1-MMP linker has predicted rigidity due to the presence of 9 proline residues, and we interpret the x-ray crystallographic structure of the MMP1 linker (68Li J. Brick P. O'Hare M.C. Skarzynski T. Lloyd L.F. Curry V.A. Clark I.M. Bigg H.F. Hazleman B.L. Cawston T.E. Structure. 1995; 3: 541-549Abstract Full Text Full Text PDF PubMed Scopus (238) Google Scholar) to also indicate that the linker is not as flexible as generally thought. Hence, MT1-LCD binding of collagen may sterically disrupt the collagenolytic configuration of sMT1-MMP at the ¾-¼ collagen cleavage site, thereby inhibiting cleavage.The importance of MT1-MMP in collagen homeostasis is supported by the finding that fibrillar type I collagen induces cell surface expression of MT1-MMP and subsequent MMP2 activation through transcriptional and nontranscriptional pathways (36Azzam H.S. Thompson E.W. Cancer Res. 1992; 52: 4540-4544PubMed Google Scholar, 37Gilles C. Polette M. Seiki M. Birembaut P. Thompson E.W. Lab. Invest. 1997; 76: 651-660PubMed Google Scholar, 38Tomasek J.J. Halliday N.L. Updike D.L. Ahern-Moore J.S., Vu, T.K. Liu R.W. Howard E.W. J. Biol. Chem. 1997; 272: 7482-7487Abstract Full Text Full Text PDF PubMed Scopus (165) Google Scholar, 39Haas T.L. Davis S.J. Madri J.A. J. Biol. Chem. 1998; 273: 3604-3610Abstract Full Text Full Text PDF PubMed Scopus (323) Google Scholar, 40Ellerbroek S.M. Fishman D.A. Kearns A.S. Bafetti L.M. Stack M.S. Cancer Res. 1999; 59: 1635-1641PubMed Google Scholar, 41Ruangpanit N. Chan D. Holmbeck K. Birkedal-Hansen H. Polarek J. Yang C. Bateman J.F. Thompson E.W. Matrix Biol. 2001; 20: 193-203Crossref PubMed Scopus (59) Google Scholar, 69Gilles C. Bassuk J.A. Pulyaeva H. Sage E.H. Foidart J.M. Thompson E.W. Cancer Res. 1998; 58: 5529-5536PubMed Google Scholar). Induction of MT1-MMP transcription is dependent on β1 integrin receptors and actin cytoskeleton rearrangement (38Tomasek J.J. Halliday N.L. Updike D.L. Ahern-Moore J.S., Vu, T.K. Liu R.W. Howard E.W. J. Biol. Chem. 1997; 272: 7482-7487Abstract Full Text Full Text PDF PubMed Scopus (165) Google Scholar, 43Seltzer J.L. Lee A.Y. Akers K.T. Sudbeck B. Southon E.A. Wayner E.A. Eisen A.Z. Exp. Cell Res. 19
What problem does this paper attempt to address?
-
Collagen binding properties of the membrane type-1 matrix metalloproteinase (MT1-MMP) hemopexin C domain. The ectodomain of the 44-kDa autocatalytic product of MT1-MMP inhibits cell invasion by disrupting native type I collagen cleavage.
Eric M Tam,Yi I Wu,Georgina S Butler,M Sharon Stack,Christopher M Overall
DOI: https://doi.org/10.1074/jbc.M206874200
2002-01-01
Abstract:Up-regulation of the collagenolytic membrane type-1 matrix metalloproteinase (MT1-MMP) leads to increased MMP2 (gelatinase A) activation and MT1-MMP autolysis. The autocatalytic degradation product is a cell surface 44-kDa fragment of MT1-MMP (Gly(285)-Val(582)) in which the ectodomain consists of only the linker, hemopexin C domain and the stalk segment found before the transmembrane sequence. In the collagenases, hemopexin C domain exosites bind native collagen, which is required for triple helicase activity during collagen cleavage. Here we investigated the collagen binding properties and the role of the hemopexin C domain of MT1-MMP and of the 44-kDa MT1-MMP ectodomain in collagenolysis. Recombinant proteins, MT1-LCD (Gly(285)-Cys(508)), consisting of the linker and the hemopexin C domain, and MT1-CD (Gly(315)-Cys(508)), which consists of the hemopexin C domain only, were found to bind native type I collagen but not gelatin. Functionally, MT1-LCD inhibited collagen-induced MMP2 activation in fibroblasts, suggesting that interactions between collagen and endogenous MT1-MMP directly stimulate the cellular activation of pro-MMP2. MT1-LCD, but not MT1-CD, also blocked the cleavage of native type I collagen by MT1-MMP in vitro, indicating an important role for the MT1-MMP linker region in triple helicase activity. Similarly, soluble MT1-LCD, but not MT1-CD or peptide analogs of the MT1-MMP linker, reduced the invasion of type I collagen matrices by MDA-MB-231 cells as did the expression of recombinant 44-kDa MT1-MMP on the cell surface. Together, these studies demonstrate that generation of the 44-kDa MT1-MMP autolysis product regulates collagenolytic activity and subsequent invasive potential, suggesting a novel feedback mechanism for the control of pericellular proteolysis.
-
Characterization of the distinct collagen binding, helicase and cleavage mechanisms of matrix metalloproteinase 2 and 14 (gelatinase A and MT1-MMP): the differential roles of the MMP hemopexin c domains and the MMP-2 fibronectin type II modules in collagen triple helicase activities
Eric M Tam,Todd R Moore,Georgina S Butler,Christopher M Overall
DOI: https://doi.org/10.1074/jbc.M407186200
2004-10-08
Abstract:Matrix metalloproteinase-2 (MMP-2, gelatinase A) and membrane type (MT)1-MMP (MMP-14) are cooperative dynamic components of a cell surface proteolytic axis involved in regulating the cellular signaling environment and pericellular collagen homeostasis. Although MT1-MMP exhibits type I collagenolytic but poor gelatinolytic activities, MMP-2 is a potent gelatinase with weak type I collagenolytic behavior. Recombinant linker/hemopexin C domain (LCD) of MT1-MMP binds native type I collagen, blocks MT1-MMP collagenolytic activity in trans, and by circular dichroism spectroscopy, induces localized structural perturbation in the collagen. These changes were reflected by enhanced cleavage of the MT1-LCD-bound collagen by the collagenases MMP-1 and MMP-8 but not by trypsin or MMP-7. Thus, the MT1-LCD alone can initiate triple helicase activity. In contrast, the native and denatured collagen binding properties of MMP-2 reside in the fibronectin type II modules, accordingly termed the collagen binding domain (CBD). Recombinant CBD (but not the MMP-2 LCD) also changed the circular dichroism spectra leading to increased MMP-1 and -8 cleavage of native collagen. However, recombinant CBD reduced gelatin and collagen cleavage by MMP-2 in trans as did CBD23, which comprises the second and third fibronectin type II modules, but not the CBD23 mutant W316A/W374A, which neither binds gelatin nor collagen. This indicates that MMP-2 and MT1-MMP bind collagen at a different site than MMP-1 and MMP-8. Thus, MMP-2 utilizes the CBD in cis for collagen binding and triple helicase activity, which compensates for the lack of collagen binding by the MMP-2 LCD. Hence, the MMP family has evolved two distinct mechanisms for collagen triple helicase activity using two structurally distinct domains, with triple helicase activity occurring independent of alpha-chain hydrolysis.
-
Activation-coupled Membrane-Type 1 Matrix Metalloproteinase Membrane Trafficking.
Yi I. Wu,Hidayatullah G. Munshi,Scott J. Snipas,Guy S. Salvesen,Rafael Fridman,M. Sharon Stack
DOI: https://doi.org/10.1042/bj20070552
IF: 3.766
2007-01-01
Biochemical Journal
Abstract:The transmembrane collagenase MT1-MMP (membrane-type 1 matrix metalloproteinase), also known as MMP-14, has a critical function both in normal development and in cancer progression, and is subject to extensive controls at the post-translational level which affect proteinase activity. As zymogen activation is crucial for MT1-MMP activity, an α1-PI (α1-proteinase inhibitor)-based inhibitor was designed by incorporating the MT1-MMP propeptide cleavage sequence into the α1-PI reactive-site loop (designated α1-PIMT1) and this was compared with wild-type α1-PI (α1-PIWT) and the furin inhibitory mutant α1-PIPDX. α1-PIMT1 formed an SDS-stable complex with furin and inhibited proMT1-MMP activation. A consequence of the loss of MT1-MMP activity was the activation of proMMP-2 and the inhibition of MT1-MMP-mediated collagen invasion. α1-PIMT1 expression also resulted in the intracellular accumulation of a glycosylated species of proMT1-MMP that was retained in the perinuclear region, leading to significantly decreased cell-surface accumulation of proMT1-MMP. These observations suggest that both the subcellular localization and the activity of MT1-MMP are regulated in a coordinated fashion, such that proMT1-MMP is retained intracellularly until activation of its zymogen, then proMT1-MMP traffics to the cell surface in order to cleave extracellular substrates.
-
The role of the C-terminal domain of human collagenase-3 (MMP-13) in the activation of procollagenase-3, substrate specificity, and tissue inhibitor of metalloproteinase interaction
V Knäuper,S Cowell,B Smith,C López-Otin,M O'Shea,H Morris,L Zardi,G Murphy
DOI: https://doi.org/10.1074/jbc.272.12.7608
1997-03-21
Abstract:Recombinant human procollagenase-3 and a C-terminal truncated form (Delta249-451 procollagenase-3) have been stably expressed in myeloma cells and purified. The truncated proenzyme could be processed by aminophenylmercuric acetate via a short-lived intermediate form (N-terminal Leu58) to the final active form (N-terminal Tyr85). The kinetics of activation were not affected by removal of the hemopexin-like C-terminal domain. The specific activities of both collagenase-3 and Delta249-451 collagenase-3 were found to be similar using two quenched fluorescent substrates, but Delta249-451 collagenase-3 failed to cleave native triple helical collagens (types I and II) into characteristic one- and three-quarter fragments. It was noted, however, that the beta1,2(I) chains of type I collagen were susceptible to Delta249-451 collagenase-3, which indicates that the catalytic domain displays telopeptidase activity, thereby generating alpha1,2(I) chains that are slightly shorter than those in native type I collagen. It can be concluded that the C-terminal domain is only essential for the triple helicase activity of collagenase-3. Binding of procollagenase-3 and active collagenase-3 to type I collagen is mediated by the C-terminal domain. Both collagenase-3 and Delta249-451 collagenase-3 hydrolyzed the large tenascin C isoform, fibronectin, recombinant fibronectin fragments, and type IV, IX, X, and XIV collagens; thus, these events were independent from C-terminal domain interactions. In contrast, the minor cartilage type XI collagen was resistant to cleavage. Kinetic analysis of the mechanism of inhibition of wild-type and Delta249-451 collagenase-3 by wild-type and mutant tissue inhibitors of metalloproteinase (TIMPs) revealed that the association rates for complex formation were influenced by both N- and C-terminal domain interactions. The C-terminal domain of wild-type collagenase-3 promoted increased association rates with the full-length inhibitors TIMP-1 and TIMP-3 and the hybrid N.TIMP-2/C.TIMP-1 by a factor of up to 33. In contrast, the association rates for complex formation with TIMP-2 and N.TIMP-1/C.TIMP-2 were only marginally affected by C-terminal domain interactions.
-
Different Collagenase Gene Products Have Different Roles in Degradation of Type I Collagen
Krane S M,Byrne M H,Lemaître V,Henriet P,Jeffrey J J,Witter J P,Liu X,Wu H,Jaenisch R,Eeckhout Y
DOI: https://doi.org/10.1074/jbc.271.45.28509
IF: 5.485
1996-01-01
Journal of Biological Chemistry
Abstract:Vertebrate collagenases, matrix metalloproteinases (MMPs), cleave type I collagen at a single helical locus. We show here that rodent interstitial collagenases (MMP-13), but not human fibroblast collagenase (MMP-1), cleave type I collagen at an additional aminoitelopeptide locus. Collagenase cDNAs and chimeric constructs in pET-3d, juxtaposing MMP-13 sequences amino-terminal to the active site in the catalytic domain and MMP-1 sequences carboxyl-terminal and vice versa, were expressed in Escherichia coli. Assays utilized collagen from wild type (+/+) mice or mice that carry a targeted mutation (r/r) that encodes substitutions in alpha 1(I) chains that prevent collagenase cleavage at the helical locus, MMP-13 and chimeric molecules that contained the MMP-13 sequences amino-terminal to the active site cleaved (+/+) collagen at the helical locus and cleaved cross-linked (r/r) collagen in the aminotelopeptide (beta components converted to ct chains), Human MMP-1 and chimeric MMP-1/MMP-13 with MMP-1 sequences aminoterminal to the active site cleaved collagen at the helical locus but not in the aminotelopeptide. All activities were inhibited by TIMP-1, 1,10-phenanthroline, and EDTA. Sequences in the distal two-thirds of the catalytic domain determine the aminotelopeptide-degrading capacity of MMP-13.
-
Identification of collagen binding domain residues that govern catalytic activities of matrix metalloproteinase-2 (MMP-2)
Margarita Mikhailova,Xiaoping Xu,Trista K Robichaud,Sanjay Pal,Gregg B Fields,Bjorn Steffensen
DOI: https://doi.org/10.1016/j.matbio.2012.10.001
Abstract:An innovative approach to enhance the selectivity of matrix metalloproteinase (MMP) inhibitors comprises targeting these inhibitors to catalytically required substrate binding sites (exosites) that are located outside the catalytic cleft. In MMP-2, positioning of collagen substrate molecules occurs via a unique fibronectin-like domain (CBD) that contains three distinct modular collagen binding sites. To characterize the contributions of these exosites to gelatinolysis by MMP-2, seven MMP-2 variants were generated with single, or concurrent double and triple alanine substitutions in the three fibronectin type II modules of the CBD. Circular dichroism spectroscopy verified that recombinant MMP-2 wild-type (WT) and variants had the same fold. Moreover, the MMP-2 WT and variants had the same activity on a short FRET peptide substrate that is hydrolyzed independently of CBD binding. Among single-point variants, substitution in the module 3 binding site had greatest impact on the affinity of MMP-2 for gelatin. Simultaneous substitutions in two or three CBD modules further reduced gelatin binding. The rates of gelatinolysis of MMP-2 variants were reduced by 20-40% following single-point substitutions, by 60-75% after double-point modifications, and by >90% for triple-point variants. Intriguingly, the three CBD modules contributed differentially to cleavage of dissociated α-1(I) and α-2(I) collagen chains. Importantly, kinetic analyses (k(cat)/K(m)) revealed that catalysis of a triple-helical FRET peptide substrate by MMP-2 relied primarily on the module 3 binding site. Thus, we have identified three collagen binding site residues that are essential for gelatinolysis and constitute promising targets for selective inhibition of MMP-2.
-
The roles of substrate thermal stability and P2 and P1' subsite identity on matrix metalloproteinase triple-helical peptidase activity and collagen specificity
Dmitriy Minond,Janelle L Lauer-Fields,Mare Cudic,Christopher M Overall,Duanqing Pei,Keith Brew,Robert Visse,Hideaki Nagase,Gregg B Fields
DOI: https://doi.org/10.1074/jbc.M606004200
2006-12-15
Abstract:The hydrolysis of collagen (collagenolysis) is one of the committed steps in extracellular matrix turnover. Within the matrix metalloproteinase (MMP) family distinct preferences for collagen types are seen. The substrate determinants that may guide these specificities are unknown. In this study, we have utilized 12 triple-helical substrates in combination with 10 MMPs to better define the contributions of substrate sequence and thermal stability toward triple helicase activity and collagen specificity. In general, MMP-13 was found to be distinct from MMP-8 and MT1-MMP(Delta279-523), in that enhanced substrate thermal stability has only a modest effect on activity, regardless of sequence. This result correlates to the unique collagen specificity of MMP-13 compared with MMP-8 and MT1-MMP, in that MMP-13 hydrolyzes type II collagen efficiently, whereas MMP-8 and MT1-MMP are similar in their preference for type I collagen. In turn, MMP-1 was the least efficient of the collagenolytic MMPs at processing increasingly thermal stable triple helices and thus favors type III collagen, which has a relatively flexible cleavage site. Gelatinases (MMP-2 and MMP-9(Delta444-707)) appear incapable of processing more stable helices and are thus mechanistically distinct from collagenolytic MMPs. The collagen specificity of MMPs appears to be based on a combination of substrate sequence and thermal stability. Analysis of the hydrolysis of triple-helical peptides by an MMP mutant indicated that Tyr(210) functions in triple helix binding and hydrolysis, but not in processing triple helices of increasing thermal stabilities. Further exploration of MMP active sites and exosites, in combination with substrate conformation, may prove valuable for additional dissection of collagenolysis and yield information useful in the design of more selective MMP inhibitors.
-
Identification of the (183)RWTNNFREY(191) region as a critical segment of matrix metalloproteinase 1 for the expression of collagenolytic activity
L Chung,K Shimokawa,D Dinakarpandian,F Grams,G B Fields,H Nagase
DOI: https://doi.org/10.1074/jbc.M004039200
2000-09-22
Abstract:Matrix metalloproteinase 1 (MMP-1) cleaves types I, II, and III collagen triple helices into (3/4) and (1/4) fragments. To understand the structural elements responsible for this activity, various lengths of MMP-1 segments have been introduced into MMP-3 (stromelysin 1) starting from the C-terminal end. MMP-3/MMP-1 chimeras and variants were overexpressed in Escherichia coli, folded from inclusion bodies, and isolated as zymogens. After activation, recombinant chimeras were tested for their ability to digest triple helical type I collagen at 25 degrees C. The results indicate that the nine residues (183)RWTNNFREY(191) located between the fifth beta-strand and the second alpha-helix in the catalytic domain of MMP-1 are critical for the expression of collagenolytic activity. Mutation of Tyr(191) of MMP-1 to Thr, the corresponding residue in MMP-3, reduced collagenolytic activity about 5-fold. Replacement of the nine residues with those of the MMP-3 sequence further decreased the activity 2-fold. Those variants exhibited significant changes in substrate specificity and activity against gelatin and synthetic substrates, further supporting the notion that this region plays a critical role in the expression of collagenolytic activity. However, introduction of this sequence into MMP-3 or a chimera consisting of the catalytic domain of MMP-3 with the hinge region and the C-terminal hemopexin domain of MMP-1 did not express any collagenolytic activity. It is therefore concluded that RWTNNFREY, together with the C-terminal hemopexin domain, is essential for collagenolytic activity but that additional structural elements in the catalytic domain are also required. These elements probably act in a concerted manner to cleave the collagen triple helix.
-
Glycosylation Broadens the Substrate Profile of Membrane Type 1 Matrix Metalloproteinase.
YI Wu,HG Munshi,R Sen,SJ Snipas,GS Salvesen,R Fridman,MS Stack
DOI: https://doi.org/10.1074/jbc.m311870200
2004-01-01
Abstract:Membrane type 1 matrix metalloproteinase (MT1-MMP) is a collagenolytic enzyme that has been implicated in normal development and in pathological processes such as cancer metastasis. The activity of MT1-MMP is regulated extensively at the post-translational level, and the current data support the hypothesis that MT1-MMP activity is modulated by glycosylation. Enzymatic deglycosylation, site-directed mutagenesis, and lectin precipitation assays were used to demonstrate that MT1-MMP contains O-linked complex carbohydrates on the Thr(291), Thr(299), Thr(300), and/or Ser(301) residues in the proline-rich linker region. MT1-MMP glycoforms were detected in human cancer cell lines, suggesting that MT1-MMP activity may be regulated by differential glycosylation in vivo. Although the autolytic processing and interstitial collagenase activity of MT1-MMP were not impaired in glycosylation-deficient mutants, cell surface MT1-MMP-catalyzed activation of pro-matrix metalloproteinase-2 (proMMP-2) required proper glycosylation of MT1-MMP. The inability of carbohydrate-free MT1-MMP to activate proMMP-2 was not a result of defective MT1-MMP zymogen activation, aberrant protein stability, or inability of the mature enzyme to oligomerize. Rather, our data support a mechanism whereby glycosylation affects the recruitment of tissue inhibitor of metalloproteinases-2 (TIMP-2) to the cell surface, resulting in defective formation of the MT1-MMP/TIMP-2/proMMP-2 trimeric activation complex. These data provide evidence for an additional mechanism for post-translational control of MT1-MMP activity and suggest that glycosylation of MT1-MMP may regulate its substrate targeting.
-
Collagenase unwinds triple-helical collagen prior to peptide bond hydrolysis
Linda Chung,Deendayal Dinakarpandian,Naoto Yoshida,Janelle L Lauer-Fields,Gregg B Fields,Robert Visse,Hideaki Nagase
DOI: https://doi.org/10.1038/sj.emboj.7600318
2004-08-04
Abstract:Breakdown of triple-helical interstitial collagens is essential in embryonic development, organ morphogenesis and tissue remodelling and repair. Aberrant collagenolysis may result in diseases such as arthritis, cancer, atherosclerosis, aneurysm and fibrosis. In vertebrates, it is initiated by collagenases belonging to the matrix metalloproteinase (MMP) family. The three-dimensional structure of a prototypic collagenase, MMP-1, indicates that the substrate-binding site of the enzyme is too narrow to accommodate triple-helical collagen. Here we report that collagenases bind and locally unwind the triple-helical structure before hydrolyzing the peptide bonds. Mutation of the catalytically essential residue Glu200 of MMP-1 to Ala resulted in a catalytically inactive enzyme, but in its presence noncollagenolytic proteinases digested collagen into typical 3/4 and 1/4 fragments, indicating that the MMP-1(E200A) mutant unwinds the triple-helical collagen. The study also shows that MMP-1 preferentially interacts with the alpha2(I) chain of type I collagen and cleaves the three alpha chains in succession. Our results throw light on the basic mechanisms that control a wide range of biological and pathological processes associated with tissue remodelling.
-
Biochemical characterization of the catalytic domain of human matrix metalloproteinase 19. Evidence for a role as a potent basement membrane degrading enzyme
J O Stracke,M Hutton,M Stewart,A M Pendás,B Smith,C López-Otin,G Murphy,V Knäuper
DOI: https://doi.org/10.1074/jbc.275.20.14809
2000-05-19
Abstract:We have recently cloned MMP-19, a novel matrix metalloproteinase, which, due to unique structural features, was proposed to represent the first member of a new MMP subfamily (Pendás, A. M., Knäuper, V. , Puente, X. S., Llano, E., Mattei, M. G., Apte, S., Murphy, G., and López-Otin, C. (1997) J. Biol. Chem. 272, 4281-4286). A recombinant COOH-terminal deletion mutant of MMP-19 (proDelta(260-508)MMP-19), comprising the propeptide and the catalytic domain, was expressed in Escherichia coli, refolded, and purified. Interestingly, we found that proDelta(260-508)MMP-19 has the tendency to autoactivate, whereby the Lys(97)-Tyr(98) peptide bond is hydrolyzed, resulting in free catalytic domain. Mutation of two residues (Glu(88) --> Pro and Pro(90) --> Val) within the propeptide latency motif did not prevent autoactivation but the autolysis rate was somewhat reduced. Analysis of the substrate specificity revealed that the catalytic domain of MMP-19 was able to hydrolyze the general MMP substrate Mca-Pro-Leu-Gly-Dpa-Ala-Arg-NH(2) and, with higher efficiency, the stromelysin substrate Mca-Pro-Leu-Ala-Nva-Dpa-Ala-Arg-NH(2). Kinetic analysis of the interactions of the catalytic domain of MMP-19 with the natural MMP inhibitors, the tissue inhibitors of metalloproteinases (TIMPs), showed strong inhibition using TIMP-2, TIMP-3, and TIMP-4, while TIMP-1 was less efficient. We also demonstrated that synthetic hydroxamic acid-based compounds efficiently inhibited the enzyme. The catalytic domain of MMP-19 was able to hydrolyze the basement membrane components type IV collagen, laminin, and nidogen, as well as the large tenascin-C isoform, fibronectin, and type I gelatin in vitro, suggesting that MMP-19 is a potent proteinase capable of hydrolyzing a broad range of extracellular matrix components. Neither the catalytic domain nor the full-length MMP-19 was able to degrade triple-helical collagen. Finally, and in contrast to studies with other MMPs, MMP-19 catalytic domain was not able to activate any of the latent MMPs tested in vitro.
-
The role of collagen charge clusters in the modulation of matrix metalloproteinase activity
Janelle L Lauer,Manishabrata Bhowmick,Dorota Tokmina-Roszyk,Yan Lin,Steven R Van Doren,Gregg B Fields
DOI: https://doi.org/10.1074/jbc.M113.513408
2014-01-24
Abstract:Members of the matrix metalloproteinase (MMP) family selectively cleave collagens in vivo. Several substrate structural features that direct MMP collagenolysis have been identified. The present study evaluated the role of charged residue clusters in the regulation of MMP collagenolysis. A series of 10 triple-helical peptide (THP) substrates were constructed in which either Lys-Gly-Asp or Gly-Asp-Lys motifs replaced Gly-Pro-Hyp (where Hyp is 4-hydroxy-L-proline) repeats. The stabilities of THPs containing the two different motifs were analyzed, and kinetic parameters for substrate hydrolysis by six MMPs were determined. A general trend for virtually all enzymes was that, as Gly-Asp-Lys motifs were moved from the extreme N and C termini to the interior next to the cleavage site sequence, kcat/Km values increased. Additionally, all Gly-Asp-Lys THPs were as good or better substrates than the parent THP in which Gly-Asp-Lys was not present. In turn, the Lys-Gly-Asp THPs were also always better substrates than the parent THP, but the magnitude of the difference was considerably less compared with the Gly-Asp-Lys series. Of the MMPs tested, MMP-2 and MMP-9 most greatly favored the presence of charged residues with preference for the Gly-Asp-Lys series. Lys-Gly-(Asp/Glu) motifs are more commonly found near potential MMP cleavage sites than Gly-(Asp/Glu)-Lys motifs. As Lys-Gly-Asp is not as favored by MMPs as Gly-Asp-Lys, the Lys-Gly-Asp motif appears advantageous over the Gly-Asp-Lys motif by preventing unwanted MMP hydrolysis. More specifically, the lack of Gly-Asp-Lys clusters may diminish potential MMP-2 and MMP-9 collagenolytic activity. The present study indicates that MMPs have interactions spanning the P23-P23' subsites of collagenous substrates.
-
Biochemical characterization of the catalytic domain of membrane-type 4 matrix metalloproteinase
H Kolkenbrock,L Essers,N Ulbrich,H Will
DOI: https://doi.org/10.1515/BC.1999.137
Abstract:A C-terminal truncated form of membrane-type 4 matrix metalloproteinase (MT4-MMP; MMP 17), lacking the hemopexin-like and transmembrane domain, was expressed in Escherichia coli. The catalytic domain was produced by tryptic activation of the recombinant proenzyme and proved to be catalytically active towards the fluorogenic substrate for matrix metalloproteinases (7-methoxycoumarin-4-yl) acetyl-Pro-Leu-Gly-Leu(3-(2,4-dinitrophenyl)-L-2,3-diaminopro-p ionyl)-Ala-Arg-NH2. In contrast to the other three MT-MMPs (MT1-, MT2-, and MT3-MMP), the catalytic domain of MT4-MMP does not activate progelatinase A, nor does it hydrolyze one of the offered extracellular matrix (ECM) proteins, such as collagen types I, II, III, IV, and V, gelatin, fibronectin, laminin or decorin. TIMP-1, a poor inhibitor of MT1-, MT2- and MT3-MMP, suppresses MT4-MMP activity effectively. The progelatinase A/TIMP-2 complex that usually reacts like TIMP-2 also inhibits MT4-MMP. TIMP-2, a strong inhibitor of other MT-MMPS, inhibits MT4-MMP at low concentrations. With increasing TIMP-2 concentration, however, activity passes through a minimum and then increases until at high TIMP-2 concentration the activity is the same as in the absence of TIMP-2. TIMP-1 or the progelatinase A/TIMP-2 complex do not prevent reactivation of MT4-MMP catalytic domain at high TIMP-2 concentrations.
-
MT1-MMP-dependent and -independent regulation of gelatinase A activation in long-term, ascorbate-treated fibroblast cultures: regulation by fibrillar collagen.
Neeracha Ruangpanit,John T Price,Kenn Holmbeck,Henning Birkedal-Hansen,Volkmar Guenzler,Xinfan Huang,Danny Chan,John F Bateman,Erik W Thompson
DOI: https://doi.org/10.1006/excr.2001.5403
IF: 4.145
2002-01-01
Experimental Cell Research
Abstract:Human skin fibroblasts were cultured long-term in the presence of ascorbic acid to allow formation of a three-dimensional collagen matrix, and the effects of this on activation of secreted matrix metalloproteinase-2 (MMP-2) were examined. Accumulation of collagen over time correlated with increased levels of both mature MMP-2 and cell-associated membrane type 1-MMP (MT1-MMP), and subsequently increased mRNA levels for MT1-MMP, providing temporal resolution of the “nontranscriptional” and “transcriptional” effects of collagen on MT-1MMP functionality. MMP-2 activation by these cultures was blocked by inhibitors of prolyl-4-hydroxylase, or when fibroblasts derived from the collagen α1(I) gene-deficient Mov-13 mouse were used. MMP-2 activation by the Mov-13 fibroblasts was rescued by transfection of a full-length α1(I) collagen cDNA, and to our surprise, also by transfection with an α1(I) collagen cDNA carrying a mutation at the C-proteinase cleavage, which almost abrogated fibrillogenesis. Although studies with ascorbate-cultured MT1-MMP−/− fibroblasts showed that MT1-MMP played a significant role in the collagen-induced MMP-2 activation, a residual MT1-MMP-independent activation of MMP-2 was seen which resembled the level of MMP-2 activation persisting when wild-type fibroblasts were cultured in the presence of both ascorbic acid and MMP inhibitors. We were also unable to block this residual activation with inhibitors specific for serinyl, aspartyl, or cysteinyl enzymes.
-
Metalloproteinases and Regulation of Endometrial Function
P. Bischof
DOI: https://doi.org/10.1007/978-3-662-10323-4_6
1997-01-01
Abstract:Matrix metalloproteinases (MMP) form a family of homologous enzymes (Table 1) which have a Zn2+ atom in their active site (see Matrisian 1990 for review). They are secreted as inactive pro enzymes (zymogens) which become activated upon partial hydrolysis whereby they loose their propeptide. They are classified in three subfamilies according to their substrate specificity: Gelatinases are represented by two enzymes, gelatinase A and B (72 and 92 kDa gelatinases, or MMP-2 and MMP-9, respectively). These proteases digest collagen type IV (the major constituent of basement membranes) and denatured collagen (gelatin). Collagenases include three proteases: the interstitial collagenase (MMP-1 or collagenase), the neutrophil collagenase (MMP-8), and collagenase 3 (MMP-13). These enzymes digest collagen types I, II, III, VII, and X. They are thus directed at digesting the collagen of the extracellular matrix of the interstitium.
-
Degradomic Identification of Membrane Type 1-Matrix Metalloproteinase as an ADAMTS9 and ADAMTS20 Substrate
Sumeda Nandadasa,Daniel Martin,Gauravi Deshpande,Karyn L Robert,M Sharon Stack,Yoshifumi Itoh,Suneel S Apte
DOI: https://doi.org/10.1016/j.mcpro.2023.100566
Abstract:The secreted metalloproteases ADAMTS9 and ADAMTS20 are implicated in extracellular matrix proteolysis and primary cilium biogenesis. Here, we show that clonal gene-edited RPE-1 cells in which ADAMTS9 was inactivated, and which constitutively lack ADAMTS20 expression, have morphologic characteristics distinct from parental RPE-1 cells. To investigate underlying proteolytic mechanisms, a quantitative terminomics method, terminal amine isotopic labeling of substrates was used to compare the parental and gene-edited RPE-1 cells and their medium to identify ADAMTS9 substrates. Among differentially abundant neo-amino (N) terminal peptides arising from secreted and transmembrane proteins, a peptide with lower abundance in the medium of gene-edited cells suggested cleavage at the Tyr314-Gly315 bond in the ectodomain of the transmembrane metalloprotease membrane type 1-matrix metalloproteinase (MT1-MMP), whose mRNA was also reduced in gene-edited cells. This cleavage, occurring in the MT1-MMP hinge, that is, between the catalytic and hemopexin domains, was orthogonally validated both by lack of an MT1-MMP catalytic domain fragment in the medium of gene-edited cells and restoration of its release from the cell surface by reexpression of ADAMTS9 and ADAMTS20 and was dependent on hinge O-glycosylation. A C-terminally semitryptic MT1-MMP peptide with greater abundance in WT RPE-1 medium identified a second ADAMTS9 cleavage site in the MT1-MMP hemopexin domain. Consistent with greater retention of MT1-MMP on the surface of gene-edited cells, pro-MMP2 activation, which requires cell surface MT1-MMP, was increased. MT1-MMP knockdown in gene-edited ADAMTS9/20-deficient cells restored focal adhesions but not ciliogenesis. The findings expand the web of interacting proteases at the cell surface, suggest a role for ADAMTS9 and ADAMTS20 in regulating cell surface activity of MT1-MMP, and indicate that MT1-MMP shedding does not underlie their observed requirement in ciliogenesis.
-
Design and synthesis of heterotrimeric collagen peptides with a built-in cystine-knot. Models for collagen catabolism by matrix-metalloproteases
J Ottl,R Battistuta,M Pieper,H Tschesche,W Bode,K Kühn,L Moroder
DOI: https://doi.org/10.1016/s0014-5793(96)01212-4
1996-11-25
Abstract:A heterotrimeric collagen peptide was designed and synthesized which contains the collagenase cleavage site (P4-P'9/10) of type I collagen linked to a C-terminal cystine-knot, and N-terminally extended with (Gly-Pro-Hyp)5 triplets for stabilization of the triple-helical conformation. By employing a newly developed regioselective cysteine pairing strategy based exclusively on thiol disulfide exchange reactions, we succeeded in assembling in high yields and in a reproducible manner the triple-stranded cystine peptide. While the single chains showed no tendency to self-association into triple helices, the heterotrimer (alpha1 alpha2 alpha1') was found to exhibit a typical collagen-like CD spectrum at room temperature and a melting temperature (Tm) of 33 degrees C. This triple-helical collagen-like peptide is cleaved by the full-length human neutrophil collagenase (MMP-8) at a single locus fully confirming the correct raster of the heterotrimer. Its digestion proceeds at rates markedly higher than that of a single alpha1' chain. In contrast, opposite digestion rates were measured with the catalytic Phe79-MMP-8 domain of HNC. Moreover, the full-length enzyme exhibits Km values of 5 microM and 1 mM for the heterotrimer and the single alpha1' chain, respectively, which compare well with those reported for collagen type I (approximately 1 microM), gelatine (approximately 10 microM) and for octapeptides of the cleavage sequence (> or = 1 mM). The high affinity of the MMP-8 for the triple-helical heterotrimer and the fast digestion of this collagenous peptide confirm the decisive role of the hemopexin domain in recognition and possibly, partial unfolding of collagen.
-
Matrix metalloproteases: variations on a theme
N Borkakoti,N. Borkakoti
DOI: https://doi.org/10.1016/s0079-6107(98)00003-0
IF: 4.799
1998-07-01
Progress in Biophysics and Molecular Biology
Abstract:The family of proteins called matrix metalloproteinases (MMPs) are a class of structurally related proteins that are collectively responsible for the metabolism of extracellular matrix proteins. These zinc and calcium dependent enzymes, which include the collagenases, stromelysins and gelatinases, are involved in normal tissue remodelling processes such as wound healing, pregnancy and angiogenesis. Under physiological conditions, in addition to the regulated proteolyses of inactive precursors to the active form, the degradative nature of these enzymes are precisely controlled by endogenous inhibitors (TIMPs). The excess syntheses and production of these proteins lead to the accelerated matrix degradation associated with diseases such as arthritis, cancer and multiple sclerosis. The MMPs have therefore proved to be attractive targets for structure based drug design. The pursuit of low molecular weight inhibitors of these proteins have encouraged structural studies on several members of family, so that the molecular details of enzyme-inhibitor interactions of the MMPs have become available. These studies provide insights into the basic structural framework of the MMP superfamily and reveal characteristics which promote specificity between individual members. The analyses of the three dimensional structure of the MMPs in the context of their primary sequence and the design and selectivity of low molecular weight inhibitors of the superfamily is the subject of this review.
biochemistry & molecular biology,biophysics
-
Membrane protease proteomics: Isotope-coded affinity tag MS identification of undescribed MT1-matrix metalloproteinase substrates.
Eric M Tam,Charlotte J Morrison,Yi I Wu,M Sharon Stack,Christopher M Overall
DOI: https://doi.org/10.1073/pnas.0305862101
2004-01-01
Abstract:By proteolytic modification of low abundant signaling proteins and membrane receptors, proteases exert potent posttranslational control over cell behavior at the postsecretion level. Hence, substrate discovery is indispensable for understanding the biological role of proteases in vivo. Indeed, matrix metalloproteinases (MMPs), long associated with extracellular matrix degradation, are increasingly recognized as important processing enzymes of bioactive molecules. MS is now the primary proteomic technique for detecting, identifying, and quantitating proteins in cells or tissues. Here we used isotopecoded affinity tag labeling and multidimensional liquid chromatography inline with tandem MS to identify MDA-MB-231 breast carcinoma cell proteins shed from the cell surface or the pericellular matrix and extracellular proteins that were degraded or processed after transfection with human membrane type 1-MMP (MT1-MMP). Potential substrates were identified as those having altered protein levels compared with the E240A inactive MT1-MMP mutant or vector transfectants. New substrates were biochemically confirmed by matrix-assisted laser desorption ionization-time-of-flight MS and Edman sequencing of cleavage fragments after incubation with recombinant soluble MT1-MMP in vitro. We report many previously uncharacterized substrates of MT1-MMP, including the neutrophil chemokine IL-8, secretory leukocyte protease inhibitor, pro-tumor necrosis factor alpha, death receptor-6, and connective tissue growth factor, indicating that MT1-MMP is an important signaling protease in addition to its traditionally ascribed roles in pericellular matrix remodeling. Moreover, the high-throughput and quantitative nature of isotope-coded affinity tag labeling combined with tandem MS sequencing is a previously undescribed degradomic screen for protease substrate discovery that should be generally adaptable to other classes of protease for exploring proteolytic function in complex and dynamic biological contexts.
-
MT1-MMP as a Key Regulator of Metastasis
Noritaka Tanaka,Takeharu Sakamoto
DOI: https://doi.org/10.3390/cells12172187
IF: 6
2023-08-31
Cells
Abstract:Membrane type1-matrix metalloproteinase (MT1-MMP) is a member of metalloproteinases that is tethered to the transmembrane. Its major function in cancer progression is to directly degrade the extracellular matrix components, which are mainly type I-III collagen or indirectly type IV collagen through the activation of MMP-2 with a cooperative function of the tissue inhibitor of metalloproteinase-2 (TIMP-2). MT1-MMP is expressed as an inactive form (zymogen) within the endoplasmic reticulum (ER) and receives truncation processing via furin for its activation. Upon the appropriate trafficking of MT1-MMP from the ER, the Golgi apparatus to the cell surface membrane, MT1-MMP exhibits proteolytic activities to the surrounding molecules such as extracellular matrix components and cell surface molecules. MT1-MMP also retains a non-proteolytic ability to activate hypoxia-inducible factor 1 alpha (HIF-1A) via factors inhibiting the HIF-1 (FIH-1)-Mint3-HIF-1 axis, resulting in the upregulation of glucose metabolism and oxygen-independent ATP production. Through various functions of MT1-MMP, cancer cells gain motility on migration/invasion, thus causing metastasis. Despite the long-time efforts spent on the development of MT1-MMP interventions, none have been accomplished yet due to the side effects caused by off-target effects. Recently, MT1-MMP-specific small molecule inhibitors or an antibody have been reported and these inhibitors could potentially be novel agents for cancer treatment.